Funder: National Institutes of Health

Due Dates: June 16, 2025 (New) | July 16, 2025 (Renewal/Resubmission/Revision) | October 16, 2025 (New) | November 16, 2025 (Renewal/Resubmission/Revision) | February 16, 2026 (New) | March 16, 2026 (Renewal/Resubmission/Revision) | June 16, 2026 (New) | July 16, 2026 (Renewal/Resubmission/Revision) | October 16, 2026 (New) | November 16, 2026 (Renewal/Resubmission/Revision)

Funding Amounts: Up to $275,000 direct costs over 2 years (max $200,000 in any single year); project period up to 2 years.

Summary: Supports secondary analysis and integration of existing data to elucidate cancer risk and related outcomes through innovative, non-clinical trial research.

Key Information: Clinical trials are not allowed; up to 10% of the budget may be used for new data generation solely for validation of key findings.